These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8803802)

  • 21. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
    Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
    Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
    Force RW; Nahata MC
    Ann Pharmacother; 1995 Jan; 29(1):10-5. PubMed ID: 7711339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
    He X; Tiballi RN; Zarins LT; Bradley SF; Sangeorzan JA; Kauffman CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2495-7. PubMed ID: 7840596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M; Liptajova D; Borovsky M; Subik J
    Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient.
    Takasuka T; Baily GG; Birch M; Anderson MJ; Law D; Denning DW
    J Infect; 1998 Jan; 36(1):57-62. PubMed ID: 9515670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
    Hughes CE; Bennett RL; Tuna IC; Beggs WH
    Antimicrob Agents Chemother; 1988 Feb; 32(2):209-12. PubMed ID: 2834995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis.
    Lynch ME; Sobel JD; Fidel PL
    J Med Vet Mycol; 1996; 34(5):337-9. PubMed ID: 8912167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
    Pfaller MA; Jones RN; Messer SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 May; 31(1):327-32. PubMed ID: 9597393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vivo and in vitro antifungal activity of fluconazole].
    Kawasaki K; Matsumura Y; Ogawa M; Tsuji A; Matsunaga T; Goto S
    Jpn J Antibiot; 1991 May; 44(5):552-61. PubMed ID: 1880935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
    Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
    Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
    Petraitis V; Petraitiene R; Kelaher AM; Sarafandi AA; Sein T; Mickiene D; Bacher J; Groll AH; Walsh TJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3959-67. PubMed ID: 15388459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
    Goff DA; Koletar SL; Buesching WJ; Barnishan J; Fass RJ
    Clin Infect Dis; 1995 Jan; 20(1):77-83. PubMed ID: 7727675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.